The STEAP2-shRNA-infected groups also exhibited smaller mean tumor volume than the MG63-1 control (Figure 4b), and IHC evaluations confirmed lower STEAP2 expression in the RNAi group (Figure 4c). Here, STEAP2 is linked to neoplasm.